Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 1.90
ICAD's Cash-to-Debt is ranked higher than
98% of the 1984 Companies
in the Global Software - Application industry.

( Industry Median: 6.56 vs. ICAD: 1.90 )
Ranked among companies with meaningful Cash-to-Debt only.
ICAD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.72 Max: No Debt
Current: 1.9
0.02
No Debt
Equity-to-Asset 0.50
ICAD's Equity-to-Asset is ranked higher than
66% of the 1901 Companies
in the Global Software - Application industry.

( Industry Median: 0.60 vs. ICAD: 0.50 )
Ranked among companies with meaningful Equity-to-Asset only.
ICAD' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.39  Med: 0.66 Max: 0.92
Current: 0.5
-0.39
0.92
Debt-to-Equity 0.33
ICAD's Debt-to-Equity is ranked lower than
99.99% of the 1109 Companies
in the Global Software - Application industry.

( Industry Median: 0.26 vs. ICAD: 0.33 )
Ranked among companies with meaningful Debt-to-Equity only.
ICAD' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.69  Med: 0.26 Max: 2.06
Current: 0.33
-0.69
2.06
Debt-to-EBITDA -0.51
ICAD's Debt-to-EBITDA is ranked lower than
99.99% of the 1011 Companies
in the Global Software - Application industry.

( Industry Median: 1.30 vs. ICAD: -0.51 )
Ranked among companies with meaningful Debt-to-EBITDA only.
ICAD' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -8.95  Med: -0.02 Max: 9.59
Current: -0.51
-8.95
9.59
Piotroski F-Score: 3
Altman Z-Score: -5.80
Beneish M-Score: -3.08
WACC vs ROIC
11.33%
-83.90%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -49.00
ICAD's Operating Margin % is ranked lower than
86% of the 1924 Companies
in the Global Software - Application industry.

( Industry Median: 4.78 vs. ICAD: -49.00 )
Ranked among companies with meaningful Operating Margin % only.
ICAD' s Operating Margin % Range Over the Past 10 Years
Min: -129.54  Med: -13.35 Max: 12.71
Current: -49
-129.54
12.71
Net Margin % -49.16
ICAD's Net Margin % is ranked lower than
85% of the 1925 Companies
in the Global Software - Application industry.

( Industry Median: 3.43 vs. ICAD: -49.16 )
Ranked among companies with meaningful Net Margin % only.
ICAD' s Net Margin % Range Over the Past 10 Years
Min: -131.18  Med: -24.17 Max: 11.62
Current: -49.16
-131.18
11.62
ROE % -55.24
ICAD's ROE % is ranked lower than
85% of the 1866 Companies
in the Global Software - Application industry.

( Industry Median: 6.42 vs. ICAD: -55.24 )
Ranked among companies with meaningful ROE % only.
ICAD' s ROE % Range Over the Past 10 Years
Min: -68.8  Med: -19.17 Max: 7.57
Current: -55.24
-68.8
7.57
ROA % -35.17
ICAD's ROA % is ranked lower than
84% of the 1992 Companies
in the Global Software - Application industry.

( Industry Median: 2.97 vs. ICAD: -35.17 )
Ranked among companies with meaningful ROA % only.
ICAD' s ROA % Range Over the Past 10 Years
Min: -51.56  Med: -10.12 Max: 6.46
Current: -35.17
-51.56
6.46
ROC (Joel Greenblatt) % -1003.63
ICAD's ROC (Joel Greenblatt) % is ranked lower than
89% of the 1954 Companies
in the Global Software - Application industry.

( Industry Median: 21.87 vs. ICAD: -1003.63 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ICAD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1592.49  Med: -300.91 Max: 178.33
Current: -1003.63
-1592.49
178.33
3-Year Revenue Growth Rate -18.50
ICAD's 3-Year Revenue Growth Rate is ranked lower than
88% of the 1618 Companies
in the Global Software - Application industry.

( Industry Median: 5.30 vs. ICAD: -18.50 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ICAD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -41.4  Med: -4.3 Max: 78.4
Current: -18.5
-41.4
78.4
3-Year EBITDA Growth Rate 43.00
ICAD's 3-Year EBITDA Growth Rate is ranked higher than
87% of the 1432 Companies
in the Global Software - Application industry.

( Industry Median: 7.30 vs. ICAD: 43.00 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ICAD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -76  Med: -16.45 Max: 217.8
Current: 43
-76
217.8
3-Year EPS without NRI Growth Rate -3.50
ICAD's 3-Year EPS without NRI Growth Rate is ranked lower than
65% of the 1341 Companies
in the Global Software - Application industry.

( Industry Median: 8.10 vs. ICAD: -3.50 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ICAD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -72.7  Med: -8.7 Max: 96.6
Current: -3.5
-72.7
96.6
GuruFocus has detected 2 Warning Signs with icad Inc ICAD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ICAD's 30-Y Financials

Financials (Next Earnings Date: 2018-03-08)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

ICAD Guru Trades in Q4 2016

Jim Simons 517,560 sh (+5.20%)
» More
Q1 2017

ICAD Guru Trades in Q1 2017

Jim Simons 501,560 sh (-3.09%)
» More
Q2 2017

ICAD Guru Trades in Q2 2017

Jim Simons 490,160 sh (-2.27%)
» More
Q3 2017

ICAD Guru Trades in Q3 2017

Jim Simons 503,760 sh (+2.77%)
» More
» Details

Insider Trades

Latest Guru Trades with ICAD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Software - Application    NAICS: 333316    SIC: 3841
Compare:TSX:ESP, LSE:CER, LSE:ZOO, TSE:3683, TSE:3390, OTCPK:GOPH, TSE:3727, TSE:2352, TSE:3910, ASX:KNM, XKRX:050960, NAS:BSQR, XPAR:ALEZV, NAS:EVOL, TSXV:PAT, XKRX:047560, LSE:ARTA, NAS:FNJN, TSE:9702, XKRX:243870 » details
Traded in other countries:HWT1.Germany,
Headquarter Location:USA
icad Inc is a provider of image analysis, work flow solutions and radiation therapy for early identification and treatment of cancer. The company has cancer detection and cancer therapy segments.

icad Inc provides cancer detection and radiation therapy and workflow solutions, primarily computer-aided detection and workflow solutions for breast, prostate and colorectal cancers. Its products include Powerlook tomo detection, Powerlook density assessment, and Vera look. The firm has also developed a technology namely Xoft Axxent electronic brachytherapy system used in the treatment of non-melanoma skin cancer, Early-stage breast cancer, and gynecological cancers.

Top Ranked Articles about icad Inc

Two Centers from The US Oncology Network Adopt iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Non-Melanoma Skin Cancer
Two Centers from The US Oncology Network Adopt iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Non-Melanoma Skin Cancer
iCAD Announces Study Demonstrating Economic and Health Benefits of Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer Treatment
iCAD’s PowerLook® Tomo Detection Experiences Growing Adoption
iCAD Announces Positive Clinical Data on Xoft System for Non-Melanoma Skin Cancer Treatment Selected as “Best of ASTRO 2017”
Imaging for Women Now Offering iCAD’s PowerLook® Tomo Detection for Digital Breast Tomosynthesis
iCAD to Report Third Quarter 2017 Financial Results on Wednesday, November 8
iCAD’s PowerLook Tomo Detection for Digital Breast Tomosynthesis Named 2017 Product of the Year by New Hampshire High Technology Council
iCAD Announces Presentation of New Clinical Data on Xoft System for Treatment of Nonmelanoma Skin Cancer and Early-Stage Breast Cancer at ASTRO 2017
iCAD to Present at the Cantor Fitzgerald Global Healthcare Conference

Ratios

vs
industry
vs
history
PB Ratio 3.32
ICAD's PB Ratio is ranked higher than
52% of the 1848 Companies
in the Global Software - Application industry.

( Industry Median: 3.13 vs. ICAD: 3.32 )
Ranked among companies with meaningful PB Ratio only.
ICAD' s PB Ratio Range Over the Past 10 Years
Min: 0.43  Med: 1.95 Max: 6.59
Current: 3.32
0.43
6.59
PS Ratio 2.15
ICAD's PS Ratio is ranked lower than
55% of the 1840 Companies
in the Global Software - Application industry.

( Industry Median: 2.37 vs. ICAD: 2.15 )
Ranked among companies with meaningful PS Ratio only.
ICAD' s PS Ratio Range Over the Past 10 Years
Min: 0.77  Med: 2.38 Max: 7.25
Current: 2.15
0.77
7.25
EV-to-EBIT -4.08
ICAD's EV-to-EBIT is ranked lower than
99.99% of the 1275 Companies
in the Global Software - Application industry.

( Industry Median: 19.16 vs. ICAD: -4.08 )
Ranked among companies with meaningful EV-to-EBIT only.
ICAD' s EV-to-EBIT Range Over the Past 10 Years
Min: -265.8  Med: -7.5 Max: 394.1
Current: -4.08
-265.8
394.1
EV-to-EBITDA -4.68
ICAD's EV-to-EBITDA is ranked lower than
99.99% of the 1386 Companies
in the Global Software - Application industry.

( Industry Median: 15.27 vs. ICAD: -4.68 )
Ranked among companies with meaningful EV-to-EBITDA only.
ICAD' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2491.9  Med: -6.1 Max: 2910.6
Current: -4.68
-2491.9
2910.6
EV-to-Revenue 1.99
ICAD's EV-to-Revenue is ranked lower than
52% of the 1894 Companies
in the Global Software - Application industry.

( Industry Median: 2.40 vs. ICAD: 1.99 )
Ranked among companies with meaningful EV-to-Revenue only.
ICAD' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.7  Med: 2 Max: 7.4
Current: 1.99
0.7
7.4
Current Ratio 1.96
ICAD's Current Ratio is ranked lower than
59% of the 1846 Companies
in the Global Software - Application industry.

( Industry Median: 1.89 vs. ICAD: 1.96 )
Ranked among companies with meaningful Current Ratio only.
ICAD' s Current Ratio Range Over the Past 10 Years
Min: 0.57  Med: 2.01 Max: 6.15
Current: 1.96
0.57
6.15
Quick Ratio 1.67
ICAD's Quick Ratio is ranked lower than
67% of the 1846 Companies
in the Global Software - Application industry.

( Industry Median: 1.75 vs. ICAD: 1.67 )
Ranked among companies with meaningful Quick Ratio only.
ICAD' s Quick Ratio Range Over the Past 10 Years
Min: 0.44  Med: 1.37 Max: 3.33
Current: 1.67
0.44
3.33
Days Inventory 153.52
ICAD's Days Inventory is ranked lower than
93% of the 1139 Companies
in the Global Software - Application industry.

( Industry Median: 17.56 vs. ICAD: 153.52 )
Ranked among companies with meaningful Days Inventory only.
ICAD' s Days Inventory Range Over the Past 10 Years
Min: 59  Med: 99.01 Max: 187.68
Current: 153.52
59
187.68
Days Sales Outstanding 96.73
ICAD's Days Sales Outstanding is ranked lower than
59% of the 1588 Companies
in the Global Software - Application industry.

( Industry Median: 66.91 vs. ICAD: 96.73 )
Ranked among companies with meaningful Days Sales Outstanding only.
ICAD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.34  Med: 65.03 Max: 96.73
Current: 96.73
50.34
96.73
Days Payable 56.06
ICAD's Days Payable is ranked lower than
51% of the 1405 Companies
in the Global Software - Application industry.

( Industry Median: 42.91 vs. ICAD: 56.06 )
Ranked among companies with meaningful Days Payable only.
ICAD' s Days Payable Range Over the Past 10 Years
Min: 47.64  Med: 108.57 Max: 186.91
Current: 56.06
47.64
186.91

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -13.80
ICAD's 3-Year Average Share Buyback Ratio is ranked lower than
78% of the 1345 Companies
in the Global Software - Application industry.

( Industry Median: -3.00 vs. ICAD: -13.80 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ICAD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -35.6  Med: -7.2 Max: -0.1
Current: -13.8
-35.6
-0.1

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 12.45
ICAD's Price-to-Net-Current-Asset-Value is ranked lower than
66% of the 1147 Companies
in the Global Software - Application industry.

( Industry Median: 7.83 vs. ICAD: 12.45 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
ICAD' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.03  Med: 11.43 Max: 1010
Current: 12.45
3.03
1010
Price-to-Tangible-Book 10.31
ICAD's Price-to-Tangible-Book is ranked lower than
73% of the 1546 Companies
in the Global Software - Application industry.

( Industry Median: 4.70 vs. ICAD: 10.31 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ICAD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.44  Med: 7.53 Max: 307.14
Current: 10.31
2.44
307.14
Price-to-Median-PS-Value 0.91
ICAD's Price-to-Median-PS-Value is ranked higher than
50% of the 1639 Companies
in the Global Software - Application industry.

( Industry Median: 1.12 vs. ICAD: 0.91 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ICAD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.36  Med: 1.31 Max: 9.63
Current: 0.91
0.36
9.63
Earnings Yield (Greenblatt) % -24.49
ICAD's Earnings Yield (Greenblatt) % is ranked lower than
87% of the 1997 Companies
in the Global Software - Application industry.

( Industry Median: 2.11 vs. ICAD: -24.49 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ICAD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -184.2  Med: -5.5 Max: 17.6
Current: -24.49
-184.2
17.6

More Statistics

Revenue (TTM) (Mil) $27.13
EPS (TTM) $ -0.81
Beta1.45
Short Percentage of Float0.32%
52-Week Range $3.13 - 6.07
Shares Outstanding (Mil)16.51

Piotroski F-Score Details

Piotroski F-Score: 33
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}